-
Try this Amy:
http://www.rxassist.org/pap-info/company_detail.cfm?CmpId=50
Good luck, Michael
A REIMBURSEMENT ASSISTANCE PROGRAM FOR
ONCOLOGY PATIENTS TAKING TEMODARSchering Corporation is dedicated to improving the lives of patients, working to develop new treatments, advancing public awareness, and supporting patient groups. COMMITMENT TO CARE® has been designed to ensure that oncology patients have access to therapy, regardless of their ability to pay, and is just one of several patient-support programs offered by Schering.
IMPORTANT FACTS ABOUT SCHERING'S COMMITMENT TO CARE®
A comprehensive compassionate drug and reimbursement assistance program in the United States, helping more than 75,000 patients since inception (1996)
Compassionate drug program eligibility based on income, with no limit on assets
Assists patients and providers with all aspects of reimbursement assistance to ensure that access to Schering oncology medications is not limited by the patient's ability to pay
UNLIKE MOST OTHER REIMBURSEMENT PROGRAMS, COMMITMENT TO CARE:
is telephone based
offers the patient easy access to a reimbursement assistance specialist with rapid follow-up
eliminates extensive paperwork
does not require that patients be indigent to qualify for assistance
PROGRAM OBJECTIVES
To help eligible patients taking TEMODAR® find reimbursement assistance for their therapy
PROGRAM BENEFITS & SERVICES
Phone assistance available weekdays, 9:00 AM to 8:00 PM ET
Simple patient enrollment procedures with minimal paperwork
Researches reimbursement assistance sources for individual patients
Verification and exploration of insurance coverage
Assistance in acquiring pre-authorization or pre-certification from insurance companies for oncology therapy
Assistance in appealing insurance company denials
Consideration for a compassionate drug program when reimbursement assistance
sources cannot be found
Referrals to state and local assistance programs
Reviews of Medicare and Medicaid benefits to ensure accurate and updated coverage information
Call toll free 1·800·521·7157
REIMBURSEMENT ASSISTANCE PROGRAM FOR
ONCOLOGY PATIENTS TAKING TEMODAR®
About Schering's COMMITMENT TO CARE®
Schering Corporation is dedicated to improving the lives of patients, working to develop new treatments, advancing public awareness, and supporting patient groups. COMMITMENT TO CARE® has been designed to ensure that oncology patients have access to therapy, regardless of their ability to pay, and is just one of several patient-support programs offered by Schering.PROGRAM OBJECTIVES
To help eligible patients taking TEMODAR® find reimbursement assistance for their therapy
Call toll free 1·800·521·7157
IMPORTANT FACTS ABOUT SCHERING'S COMMITMENT TO CARE®
A comprehensive compassionate drug and reimbursement assistance program in the United States, helping more than 75,000 patients since inception (1996)Compassionate drug program eligibility based on income, with no limit on assets
Assists patients and providers with all aspects of reimbursement assistance to ensure that access to Schering oncology medications is not limited by the patient's ability to pay
UNLIKE MOST OTHER REIMBURSEMENT PROGRAMS, COMMITMENT TO CARE:
is telephone based
offers the patient easy access to a reimbursement assistance specialist with rapid follow-up
eliminates extensive paperwork
does not require that patients be indigent to qualify for assistance
Schering's COMMITMENT TO CARE® is open to any and all callers — from patients to professionals.
PROGRAM BENEFITS & SERVICES
Phone assistance available weekdays, 9:00 AM to 8:00 PM ET
Simple patient enrollment procedures with minimal paperwork
Researches reimbursement assistance sources for individual patients
Verification and exploration of insurance coverage
Assistance in acquiring pre-authorization or pre-certification from insurance companies for oncology therapy
Assistance in appealing insurance company denials
Reviews of Medicare and Medicaid benefits to ensure accurate and updated coverage information
Consideration for a compassionate drug program when reimbursement assistance sources cannot be found
Referrals to state and local assistance programs
For your patients taking TEMODAR®
Reimbursement assistance informationEasy access to a reimbursement specialist to explore financial assistance options:
reimbursement assistance
patient assistance programs
insurance verification, pre-authorization or pre-certification, and denial appeals
referrals for assistance
Medication may be provided at no cost based on financial need and insurance coverage status
Schering's COMMITMENT TO CARE®
Reimbursement Assistance Program
1·800·521·7157
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.
